Meningiomas are the most common intracranial tumor, making up more than a third of all
primary central nervous system (CNS) tumors. They are mostly benign tumors that can be …

Meningiomas are the most common primary intracranial tumors. The majority of
meningiomas are benign, but they can present different grades of dedifferentiation from …

Meningiomas are classified based on histological features, but genetic and epigenetic
features are emerging as relevant biomarkers for outcome prediction and may supplement …

Background There is a critical need for objective and reliable biomarkers of outcome in
meningiomas beyond WHO classification. Loss of H3K27me3 has been reported as a …

This study aims to determine how randomly splitting a dataset into training and test sets
affects the estimated performance of a machine learning model and its gap from the test …

Objective: The purpose of the current study is to investigate whether texture analysis-based
machine learning algorithms could help devise a non-invasive imaging biomarker for …

Background Brain invasion by meningioma is a stand-alone criterion for tumor atypia in the
2016 World Health Organization classification, but no imaging parameter has yet been …

Somatostatin receptor (SSTR) 2, widely expressed in meningioma, is a G-protein-coupled
receptor and can be activated by somatostatin or its synthetic analogs. SSTR2 is therefore …

Objectives: Identify the etiology of meningioma. Describe the common physical signs seen in
patients with meningioma. Outline the management options for patients with meningioma …

Background Brain invasion in meningioma has independent associations with increased
risks of tumor progression, lesion recurrence, and poor prognosis. Therefore, this study …